ACLU Should Be Hit With Rule 11 Sanctions
2 comments | Page viewed 158 timesPosted: Friday, November 20, 2009 @ 2:40 pm
Posted in: Anti-patent Nonsense, Biotechnology, Dale B. Halling, Gene Patents, IP News, IPWatchdog.com Blog, Patent Fools™, Patent Litigation
In the ACLU v. Myriad case, the ACLU has alleged that the patents involved in the case cover genes found in nature. This statement is so patently (pun intended) false, that the ACLU either purposely deceived the court or is guilty of gross negligence about the facts plead in the case. As Gene points out in his post, Fired up: Challenging the Constitutionality of the Patent Act none of the claims in question cover genes found in nature. These claims are directed to screening, identifying, and isolating the BRCA1/2 genetic sequences. This is not a claim to the gene itself, but methods of screening, identifying and isolating the genes, which are processes not found in nature. This is no different than a patent having claims for screening, identifying or isolating gold. Gold is found in nature, but methods for screening, identifying, or isolating gold are not found in nature and are definitely patentable subject matter. The ACLU either purposely deceived the court when they stated “The patents cover the human genes themselves”, paragraphs 3-4, 55-67, & 102 of the complaint, or showed gross negligence about the facts pleaded in their complaint.









Recently I received an e-mail with a link alerting me to something posted on the 


Unlike Gene I did not really plan very well. I did not have credentials and am not (yet) a member of the Court. So, I was in line with the public. A patent centric public, but the public none-the-less. My fellow line standers included: Law students headed to taking the patent bar; a 
Later today the 

I just so happened to stumble across an interesting article declaring me 

In perhaps the worst 











